首页> 美国卫生研究院文献>The Journal of Pharmacology and Experimental Therapeutics >β2 Subunit-Containing Nicotinic Receptors Mediate Acute Nicotine-Induced Activation of Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Pathways in Vivo
【2h】

β2 Subunit-Containing Nicotinic Receptors Mediate Acute Nicotine-Induced Activation of Calcium/Calmodulin-Dependent Protein Kinase II-Dependent Pathways in Vivo

机译:包含β2亚基的烟碱受体介导急性。 尼古丁诱导的钙/钙调蛋白依赖性蛋白激酶的激活。 II依赖的体内途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nicotine is the addictive component of tobacco, and successful smoking cessation therapies must address the various processes that contribute to nicotine addiction. Thus, understanding the nicotinic acetylcholine receptor (nAChR) subtypes and subsequent molecular cascades activated after nicotine exposure is of the utmost importance in understanding the progression of nicotine dependence. One possible candidate is the calcium/calmodulin-dependent protein kinase II (CaMKII) pathway. Substrates of this kinase include the vesicle-associated protein synapsin I and the transcription factor cAMP response element-binding protein (CREB). The goal of these studies was to examine these postreceptor mechanisms after acute nicotine treatment in vivo. We first show that administration of nicotine increases CaMKII activity in the ventral tegmental area (VTA), nucleus accumbens (NAc), and amygdala. In β2 nAChR knockout (KO) mice, nicotine does not induce an increase in kinase activity, phosphorylated (p)Synapsin I, or pCREB. In contrast, α7 nAChR KO mice show nicotine-induced increases in CaMKII activity and pCREB, similar to their wild-type littermates. Moreover, we show that when animals are pretreated with the CaMKII inhibitors 4-[(2S)-2-[(5-isoquinolinylsulfonyl) methylamino]-3-oxo-3-(4-phenyl-1-piperazinyl)propyl]phenyl isoquinolinesulfonic acid ester (KN-62) and N-[2-[[[3-(4-chlorophenyl)-2 propenyl]methylamino]methyl]phenyl]-N-(2-hydroxyethyl)-4-methoxybenzenesulphonamide (KN-93), nicotine-induced increase in the kinase activity and pCREB was attenuated in the VTA and NAc, whereas pretreatment with (2-[N-(4-methoxybenzenesulfonyl)]amino-N-(4-chlorocinnamyl)-N-methylbenzylamine, phosphate) (KN-92), the inactive analog, did not alter the nicotine-induced increase in pCREB. Taken together, these data suggest that the nicotine-induced increase in CaMKII activity may correlate with the nicotine-induced increase in pSynapsin I and pCREB in the VTA and NAc via β2 subunit-containing nAChRs.
机译:尼古丁是烟草的成瘾成分,成功的戒烟治疗必须解决导致尼古丁成瘾的各种过程。因此,了解烟碱乙酰胆碱受体(nAChR)亚型和烟碱暴露后激活的后续分子级联对于了解烟碱依赖性的进展至关重要。一种可能的候选药物是钙/钙调蛋白依赖性蛋白激酶II(CaMKII)途径。该激酶的底物包括囊泡相关蛋白突触蛋白I和转录因子cAMP反应元件结合蛋白(CREB)。这些研究的目的是在体内急性尼古丁治疗后检查这些受体后机制。我们首先显示尼古丁的管理增加了腹侧被盖区(VTA),伏伏核(NAc)和杏仁核中的CaMKII活性。在β2nAChR基因敲除(KO)小鼠中,尼古丁不会诱导激酶活性,磷酸化(p)突触素I或pCREB的增加。相反,α7nAChR KO小鼠表现出尼古丁诱导的CaMKII活性和pCREB的增加,类似于它们的野生型同窝仔。此外,我们证明了使用CaMKII抑制剂对动物进行预处理时 4-[(2S)-2-[(5-异喹啉基磺酰基) 甲基氨基] -3-氧代-3-(4-苯基-1-哌嗪基)丙基]苯基 异喹啉磺酸酯(KN-62)和 N- [2-[[[3-(4-氯苯基)-2 丙烯基] [甲基氨基]甲基]苯基] -N-(2-羟乙基)-4-甲氧基苯磺酰胺 (KN-93),尼古丁诱导的激酶活性增加,pCREB为 在VTA和NAc中减弱,而用 (2- [N-(4-甲氧基苯磺酰基)]氨基-N-(4-氯肉桂基)-N-甲基苄胺 磷酸酯(KN-92),无活性的类似物,不会改变尼古丁引起的 pCREB增加。综合来看,这些数据表明 尼古丁引起的CaMKII活性增加可能与 尼古丁引起的VTA和NAc中pSynapsin I和pCREB的增加通过 含β2亚基的nAChRs。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号